Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
April 23 2019
The MedTech company Defymed from Strasbourg has obtained a grant of 230,000 euros for the developmen...
March 18 2019
Marseille, March 26-29th 2019: Defymed will participate to the annual congress of the Francophone Di...